Withdrawal of sibutramine for weight loss: where does this leave clinicians?
Czernichow
Sébastien
S
Batty
G David
GD
D001067:Appetite Depressants / Q000008:administration & dosage / Q000009:adverse effects*; D003503:Cyclobutanes / Q000008:administration & dosage / Q000009:adverse effects*; D017277:Drug Approval; D006801:Humans; D009765:Obesity / Q000188:drug therapy* / Q000453:epidemiology; D012307:Risk Factors
D001067:Appetite Depressants; D003503:Cyclobutanes; C058254:sibutramine